COMMITMENTS AND CONTINGENCIES (Tables)

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2019 and 2018 is as follows (in thousands):



Three Months Ended March 31, 2019	Contingent Consideration Liability Related to Acquisition of Derma
	Long-term
Balance as of January 1, 2019	$	230
Balance as of March 31, 2019	$	230



Three Months Ended March 31, 2018	Contingent Considerations Liabilities Related to Acquisition of Derma				Contingent Consideration Liability Related to Acquisition of Confluent Surgical, Inc.		Location in Financial Statements
	Short-term		Long-term		Short-term
Balance as of January 1, 2018	$	315	$	1,387	$	22,478
Loss from change in fair value of contingent consideration liabilities	—		32		1,422		Selling, general and administrative
Balance as of March 31, 2018	$	315	$	1,419	$	23,900